Ketan K. Badani on Muck Rack

Ketan K. Badani

New York
As seen in: Color Research & Application, ONCOLOGY journal, OncLive, European Urology, UroToday, Urologic Clinics of North America, Targeted Oncology, BJU International Journal
Vice Chair & Professor of Urology, Icahn School of Medicine at Mount Sinai Health. Director, Kidney Cancer Center & Robotic Surgery. views = mine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ketan K.

Contact Ketan K., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Artificial Intelligence May Expedite Prognoses in Cancer Care

|
By Ketan K. Badani
| ONCOLOGY journal Verified
CancerNetwork® spoke with Ketan K. Badani, MD, vice chairman of Urology and Robotics and director of the Comprehensive Kidney Cancer Center and Reconstructive Urology at Mount Sinai Health System, about how he expects artificial intelligence (AI) to become a standard of care in 5 years. Badani prefaced the discussion by acknowledging fears associated with the emergence of AI before suggesting that it creates the potential for opportunities in enhancing cancer care.
Open in Who Shared Issue with article?

AI Use in Surgeries for Prostate Cancer May Help Standardize Outcomes

|
By Ketan K. Badani
| ONCOLOGY journal Verified
Artificial intelligence (AI) may have the potential to better standardize surgery outcomes in patients undergoing prostatectomies and train doctors to more effectively perform them, according to Ketan K. Badani, MD CancerNetwork® spoke with Badani, vice chairman of Urology and Robotics and director of the Comprehensive Kidney Cancer Center and Reconstructive Urology at Mount Sinai Health System, about how AI may be integrated into patient care.
Open in Who Shared Issue with article?

Vaccine Trials Ongoing in Locally Advanced Oligometastatic Prostate Cancer

|
By Ketan K. Badani
| ONCOLOGY journal Verified
CancerNetwork® spoke with Ketan K. Badani, MD, vice chairman of Urology and Robotics and director of the Comprehensive Kidney Cancer Center and Reconstructive Urology at Mount Sinai Health System, about the phase 1 poly-ICLC trial (NCT03262103), which tested the safety of sequential intratumoral plus systemic intramuscular injection of poly-ICLC.
Open in Who Shared Issue with article?
See all 8 licensed articles (13 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified